BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 7777181)

  • 21. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
    Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
    J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.
    Yuan CS
    Eur J Pharmacol; 1996 Oct; 314(1-2):27-32. PubMed ID: 8957215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
    Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I; Napier TC
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioural effects of selective mu-, kappa-, and delta-opioid agonists in neonatal rats.
    Jackson HC; Kitchen I
    Psychopharmacology (Berl); 1989; 97(3):404-9. PubMed ID: 2541460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential antagonism of mu agonists by U50,488H in the rat.
    Porreca F; Tortella FC
    Life Sci; 1987 Dec; 41(23):2511-6. PubMed ID: 2824958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H.
    Bot G; Chahl LA; Brent PJ; Johnston PA
    Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioidergic modulation of voltage-activated K+ currents in magnocellular neurons of the supraoptic nucleus in rat.
    Müller W; Hallermann S; Swandulla D
    J Neurophysiol; 1999 Apr; 81(4):1617-25. PubMed ID: 10200198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of kappa-opioid receptor mediated tolerance in the guinea-pig ileum by chronic co-administration of dihydropyridines.
    Garaulet JV; Laorden ML; Milanés MV
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):72-9. PubMed ID: 8832591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intrathecal mu, delta, and kappa agonists on thermally evoked cardiovascular and nociceptive reflexes in halothane-anesthetized rats.
    Nagasaka H; Yaksh TL
    Anesth Analg; 1995 Mar; 80(3):437-43. PubMed ID: 7864404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
    Gullapalli S; Ramarao P
    Neuropharmacology; 2002 Mar; 42(4):467-75. PubMed ID: 11955518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
    Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.
    Miaskowski C; Taiwo YO; Levine JD
    Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between inhibitory effect of endogenous opioid via mu-receptors and muscarinic autoinhibition in acetylcholine release from myenteric plexus of guinea pig ileum.
    Nishiwaki H; Saitoh N; Nishio H; Takeuchi T; Hata F
    Jpn J Pharmacol; 1998 Aug; 77(4):279-86. PubMed ID: 9749928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of specific activation of mu-, delta- and kappa-opioid receptors on the secretion of luteinizing hormone and prolactin in the ovariectomized rat.
    Leadem CA; Yagenova SV
    Neuroendocrinology; 1987 Feb; 45(2):109-17. PubMed ID: 3033534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nor-binaltorphimine decreases deprivation and opioid-induced feeding.
    Levine AS; Grace M; Billington CJ; Portoghese PS
    Brain Res; 1990 Nov; 534(1-2):60-4. PubMed ID: 1963567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses.
    Yuan CS; Foss JF
    Neuropharmacology; 1999 Mar; 38(3):425-32. PubMed ID: 10219980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.